Guo-Qing Wang Selected Research

Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)

9/2009	Aryl hydrocarbon receptor expression is associated with a family history of upper gastrointestinal tract cancer in a high-risk population exposed to aromatic hydrocarbons.
3/2004	Polycyclic aromatic hydrocarbon-DNA adducts determined by semiquantitative immunohistochemistry in human esophageal biopsies taken in 1985.
12/2002	Semiquantitation of polycyclic aromatic hydrocarbon-DNA adducts in human esophagus by immunohistochemistry and the automated cellular imaging system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guo-Qing Wang Research Topics

Disease

11	Neoplasms (Cancer) 04/2016 - 02/2003
6	Inflammation (Inflammations) 12/2022 - 01/2017
5	Parkinson Disease (Parkinson's Disease) 12/2021 - 01/2017
4	Esophageal Squamous Cell Carcinoma 05/2014 - 01/2009
4	Esophageal Neoplasms (Esophageal Cancer) 01/2012 - 12/2002
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2021 - 01/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2017
3	Carcinoma (Carcinomatosis) 05/2013 - 02/2003
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 03/2020
2	Gliosis 09/2019 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 05/2014 - 05/2013
2	Vesicular Stomatitis 10/2008 - 03/2007
1	Hemorrhage 12/2022
1	COVID-19 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Diabetes Mellitus 01/2022
1	AIDS-Related Complex (ARC) 10/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Dementia (Dementias) 01/2021
1	Cognitive Dysfunction 03/2020
1	Neuroinflammatory Diseases 01/2020
1	Carcinogenesis 01/2018
1	Dyskinesias (Dyskinesia) 01/2018
1	Ischemia 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2016
1	Healthcare-Associated Pneumonia 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2016
1	Shock 01/2015
1	Adenocarcinoma 05/2013
1	Alopecia (Baldness) 01/2013
1	Lactose Intolerance (Intolerance, Lactose) 06/2012
1	Aneuploidy (Aneuploid) 01/2012

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2007
5	Dopamine (Intropin)FDA LinkGeneric 12/2021 - 01/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 04/2010
3	VaccinesIBA 01/2022 - 03/2020
3	AntioxidantsIBA 01/2020 - 01/2013
3	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 09/2009 - 12/2002
2	Ellagic AcidIBA 01/2020 - 09/2019
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2015
2	Pepsinogen A (Pepsinogen)IBA 05/2014 - 01/2009
2	Pepsinogen CIBA 05/2014 - 01/2009
2	ParaffinIBA 07/2010 - 03/2004
2	Coloring Agents (Dyes)IBA 11/2007 - 05/2004
2	IodineIBA 05/2004 - 02/2003
1	necrostatin-1IBA 12/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	InflammasomesIBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	NLR ProteinsIBA 01/2020
1	4-iodobenzenesulfonamideIBA 12/2019
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 09/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Nerve Growth Factors (Neurotrophins)IBA 01/2019
1	Levodopa (L Dopa)FDA LinkGeneric 01/2018
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2018
1	Protease La (Endopeptidase La)IBA 01/2018
1	mitochondrial transcription factor AIBA 01/2018
1	Aconitate Hydratase (Aconitase)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	RotenoneIBA 01/2017
1	Adenosine Triphosphatases (ATPase)IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	icariinIBA 01/2017
1	epimedii flavoneIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	CarboxypeptidasesIBA 04/2016
1	Staphylococcal Protein A (Protein A)IBA 04/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	AutoantibodiesIBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	AntigensIBA 01/2016
1	Interleukin-27 (Interleukin 27)IBA 01/2016
1	Phospholipase A2 ReceptorsIBA 01/2016
1	Lugol's solution (Lugol's iodine)IBA 06/2015
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2015
1	ReninIBA 01/2015
1	CorticosteroneIBA 01/2015
1	Captopril (Capoten)FDA LinkGeneric 01/2015
1	Superoxide DismutaseIBA 01/2015
1	AngiotensinogenIBA 01/2015
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2015
1	tempolIBA 01/2015
1	4-vinyl-2,6-dimethoxyphenolIBA 05/2013
1	thiazolyl blueIBA 05/2013
1	GalactosidasesIBA 06/2012

Therapy/Procedure

6	Therapeutics 01/2022 - 03/2007
1	Oral Administration 01/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2021
1	Immunotherapy 03/2020
1	Chemoradiotherapy 12/2019
1	Radiotherapy 12/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Hepatectomy 01/2017
1	Denervation 01/2015